[Ip-health] UN Special Rap. Session: Access to Medicines & US Trade Policy

Matthew Kavanagh matthew at healthgap.org
Tue Oct 26 08:18:36 PDT 2010


Note, an important event with implications for access to AIDS and  
other essential medicines... Open to the public.

                                --NOTICE--
WITH U.N. SPECIAL RAPPORTEUR ON THE RIGHT TO HEALTH, ANAND GROVER:
PUBLIC CONSULTATION ON CURRENT TRADE POLICIES, ACCESS TO MEDICINES AND  
THE RIGHT TO HEALTH

Examination of the  Impact of the U.S. Special 301 Program on Access  
To Medicines and The Right To Health

October 28th
9:30-12:30
To Be Convened at American University Washington, College of Law, 4910  
Massachusetts Ave., NW, Washington, DC
Webcast: wcl.american.edu/pijip

Government officials, civil society representatives, academics, and  
other expert groups from the U.S., United Nations, Thailand, Brazil,  
India, and Ecuador will present information on how the U.S. “Special  
301” program to promote intellectual property norms in developing  
countries is affecting access to affordable medicines and public  
health. The Special 301 Program has been the subject of a human rights  
complaint by numerous global public health organizations, filed with  
the United Nations during the International AIDS Conference in Vienna  
Austria on July 20 2010.

Questions addressed will include:
-          Have the Special 301 Watch List and similar mechanisms  
impacted the availability and price of essential medicines?
-          Why are countries placed on the Special 301 Watch List and  
how does this mechanism impact developing country policy space related  
to the human right to health?

Review a copy of the complaint Online

The U.N. Special Rapporteur on the Right to Health was appointed by  
the U.N.  Human Rights Commission to focus on the right of everyone to  
the enjoyment of the highest attainable standard of physical and  
mental health. Read the mandate.

Civil Society Consultation on ACTA & Enforcement

1:00-2:30

The morning will be followed by an afternoon session 1:00-2:30 on the  
potential impact of the Anti-Counterfeiting Trade Agreement and other  
aspects of the international intellectual property enforcement agenda  
on access to affordable medications.

To register, please go to: http:// wcl.american.edu/secle/registration





More information about the Ip-health mailing list